Cochlear Profit Results Up

Submitted by Share Trading on 11 August, 2010 - 11:41

Hearing implant systems manufacturer, Cochlear (ASX:COH) has announced a 19 percent increase in net profit at $130.5 million. The company has also announced a final dividend, which is 60 percent franked at $1.05.

  • Net Profit after Tax (NPAT) of $155.2 million, up 19%.
  • Successful launch of new cochlear implant system Cochlear™ Nucleus® 5 with second half CI unit sales up 20% and full year up 13% to 21,023 units
  • Total revenue up 6% to $734.8 million, with sales up 12% in constant currency
  • Due to 4% margin expansion EBIT up 20% to $220.5 million
  • Free Cash Flow at $166 million up 50% on last year
  • Final dividend of $1.05c per share (60% franked) bringing total dividends for the year to $2.00 per share, up 14% on the prior year.

Total Revenue

Total revenues were $734.8 million, up 6%. Sales, excluding FX contracts, were $696.2 million, down 2%. In constant currency (that is restating F09 at F10 FX rates), F10 sales were up 12% compared to F09.

Cochlear implant (CI) sales which included accessories and sound processor upgrades were $603.7 million, down 2%, up 13% in constant currency.
Cochlear implant unit sales increased 13% to 21,023 units, with second half unit sales up 20% reflecting the momentum of the launch of the Nucleus 5 which commenced in the first half. This momentum meant that the majority of implants sold in the second half of F10 were Nucleus 5.

Baha sales of $92.5 million grew 9% in constant currency (down 5% in reported currency).

Regional sales reflected growth in constant currency in all regions: Americas sales of $307.6 million were up 18% in constant currency (2% in reported currency) following the Cochlear Nucleus 5 product releases. EMEA (Europe, Middle East and Africa) sales of $291.5 million were up 7% in constant currency (down 9% in reported currency). The Cochlear Nucleus 5 launch drove double digit growth in the developed countries where it was released.

Tender sales were variable and overall were down on the prior year. Asia Pacific sales of $97.1 million were up 5% and 13% in constant currency. This included 500 units sold into China for the donation program.

Cochlear Expenses

Expenses grew less than sales growth. SG&A fell 1% to $227.4 million (up 7% in constant currency). Research and Development expense fell 2% to $94.9 million (up 1% in constant currency). This controlled approach to expenses combined with the sales growth led to margin expansion with EBIT/Total Revenue improving 4% to 30%.

Free Cash Flow

Cash from operating activities was up 22% to a record $179.5 million. Free cash flow of $166 million was up 50%. Trade receivables of $159.5 million grew 4% over the prior year and debtors days fell to 72 days (F09 73 days). Inventory fell 1% to $104.4 million.

New Headquarters

Cochlear’s new global headquarters building program is on track for completion by the end of the calendar year. On practical completion Macquarie University will pay Cochlear approximately $128 million and lease the building to Cochlear on commercial terms. Some $74.3 million had been spent on the building by 30th June 2010.

Capital management

Total net debt was $113.9 million at 30th June 2010. Excluding $72.8 million of net debt for the new global headquarters at Macquarie University net debt at 30th June 2010 was $41.1 million. This equates to a net gearing ratio of 9% (F09, 21%) defined as (net debt / net debt + equity).

Foreign Exchange

Foreign exchange movements can impact Cochlear’s financial results. In F10 the average Australian Dollar rates appreciated 16% against the USD and 15% against the Euro, compared to F09.

Gains from FX contracts were $38.6 million for the year. This offset some of the effects of an appreciating AUD, although if F09 rates had applied in F10, NPAT would have been $15.1 million more than reported (ie. $170.3 million).

Cochlear Dividends

A final partially franked dividend of $1.05 (franked to 60%) per share was declared and will be paid on 23rd September 2010 based on a record date of 2nd September 2010. The dividend for the year is $2.00, up 14%. The unfranked portion of the dividend has been declared Conduit Foreign Income. This is beneficial to our overseas shareholders as no withholding tax applies to the dividend.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <blockquote> <h2> <h3>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
7 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!